# Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma

> **NCT02703467** · — · COMPLETED · sponsor: **Imperial College London** · enrollment: 70 (actual)

## Conditions studied

- Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02703467
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-01
- **Primary completion:** 2016-06-30
- **Final completion:** 2016-06-30
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2019-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02703467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02703467, "Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02703467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*